Universidad Autonoma De Guadalajara, Mexico Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2006
NCT00516659
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Universidad Autonoma de Guadalajara | Universidad Autonoma Guadalajara, Mexico

Active Ingredients

Drugs in Phase 2 Trials (3)

favipiravir (1 trial)

heat-labile enterotoxin of e. coli (1 trial)

nitazoxanide (Alinia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diarrhea (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3